Award
NIH Reporter #5R01CA273224-05
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Recipient
Memorial Sloan-Kettering Cancer Center
Award Amount
$734,405.00
Ceiling
$734,405.00
Awarded
July 07, 2026
Identifier
5R01CA273224-05
Award for a research project integrating imaging and plasma cell-free DNA sequencing to monitor treatment response and predict cancer progression, funded by the National Cancer Institute.
Description
This project aims to evaluate the correlation between early changes in circulating tumor DNA (ctDNA) and treatment response in cancer patients, leveraging advanced imaging and genomic sequencing techniques. The study is funded by the NIH and involves collaboration with Memorial Sloan-Kettering Cancer Center.